R&D Tax Relief After the 2024 Merger: What UK Founders Are Getting Wrong in 2026

This year, I've had many conversations with business owners and founders who were under the impression that the recent changes to the UK's R&D tax relief regime would not significantly affect their operations.

Often, this assumption has proven to be costly in practice.

What we are observing in 2026 is not a decline in innovation, but rather a widespread misunderstanding of how the rules have evolved.

Many businesses continue to approach R&D claims as they did prior to the merger of the SME and RDEC schemes. The reality is that eligibility criteria, evidence requirements, and expectations surrounding documentation have all changed considerably.

Strong R&D claims are not something you build at the end of your financial year. They are a product of consistent effort throughout the year, driven by disciplined record-keeping, clear project documentation, and a genuine understanding of the technical challenges your work addresses.

The businesses that are currently seeing the most favourable outcomes are those that treat R&D planning as an integral business discipline, rather than merely a tax exercise.

They integrate it into their operational processes from the outset, ensuring that the necessary evidence and narratives are captured as innovation occurs.

This proactive approach allows for a far more robust and defensible claim. It also helps you to remain agile, adapting to any further refinements in the tax regime, and importantly, ensures that the valuable work you are doing in R&D is appropriately recognised and rewarded.